Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
Targeted Conditions
Biktarvy is approved for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 14 kg who:
It is a complete single-tablet regimen and does not require combination with other antiretroviral drugs.
Off-Label Usage
Off-label use is uncommon, but may include:
These uses are not FDA-approved and should only be considered under professional supervision.
Drug Classification Overview
Biktarvy is a fixed-dose combination of three antiretroviral agents:
Bictegravir – an integrase strand transfer inhibitor (INSTI)
Emtricitabine – a nucleoside reverse transcriptase inhibitor (NRTI)
Tenofovir alafenamide (TAF) – a nucleotide reverse transcriptase inhibitor (NtRTI)
Together, these drugs block different stages of HIV replication.
Manufacturer in the USA, Mexico, and Canada
United States: Gilead Sciences
Canada: Gilead Sciences Canada, Inc.
Mexico: Gilead Sciences Mexico S. de R.L. de C.V.
Available Strengths and Dosage Forms – United States, Mexico, and Canada
Country Comparison – United States vs Mexico and Canada
Average Retail Price (Monthly Treatment)
Canada: Approximately 40–55% savings compared to U.S. retail price
Mexico: Approximately 45–60% savings compared to U.S. retail price
Savings may vary depending on availability, prescription requirements, classification (controlled, specialty, etc.), and cold chain logistics if applicable.
Where to Buy USA
Availability may vary depending on insurance, pharmacy network, and whether a specialty pharmacy is required.
Storage Requirements
Key Benefits
Shipping from Canada
This medication is accessed through fully licensed Canadian pharmacies regulated by Health Canada. All pharmacies included in the MedicalMex network undergo a rigorous review and verification process to ensure compliance with national standards, patient safety, and medication authenticity.
MedicalMex facilitates:
Buying from Mexico
This medication is also available through certified pharmacies in Mexico regulated by COFEPRIS (Mexico’s national health authority). All partners in the MedicalMex network must pass a rigorous review and certification process before being approved for patient access.
MedicalMex facilitates:
Side Effects
Seek medical help if any unusual symptoms occur.
Warnings and Precautions
Alternative Medications (by Indication)
Dovato (dolutegravir/lamivudine)
Juluca (dolutegravir/rilpivirine)
Triumeq (dolutegravir/abacavir/lamivudine)
Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)
Complera (rilpivirine/emtricitabine/tenofovir disoproxil fumarate)
